Literature DB >> 16916656

Mannose-binding lectin genotype and invasive pneumococcal infection.

Leen Moens1, Erna Van Hoeyveld, Willy E Peetermans, Christiane De Boeck, Jan Verhaegen, Xavier Bossuyt.   

Abstract

Invasive pneumococcal disease is a serious infection that primarily affects young children and elderly or immunocompromised persons, but it also can affect healthy persons. Mannose-binding lectin (MBL) is a mediator of innate host immunity that activates the complement pathway and directly opsonizes pathogens. Variant structural codon and promoter MBL alleles have been associated with susceptibility to infections. Sixty-three Belgian patients with invasive pneumococcal disease and 162 healthy Belgian controls were genotyped for MBL alleles. We found a nonsignificant increased risk between the MBL structural codon variants (52, 54, and 57) and invasive pneumococcal disease. Combining our data with similar data from Kronberg et al. (J Infect Dis 2002;185:1517-20) indicated that MBL structural variants contributed to a small but significant increased risk of invasive pneumococcal disease. On the other hand, the -221 and -550 promoter allele distribution and the prevalence of the combined MBL structural and promoter -221 variant alleles were not significantly different between the patient group and the control group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916656     DOI: 10.1016/j.humimm.2006.04.014

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

Review 1.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  The investigation of allele and genotype frequencies of human C3 (rs2230199) in south Iranian population.

Authors:  Najmeh Bazyar; Negar Azarpira; Saied Reza Khatami; Hamid Galehdari
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

4.  The Prognostic Value of Mannose-Binding Lectin in Community-Acquired Pneumonia.

Authors:  Roxana Taras; Georgiana Capitanescu; Marcela Ionescu; Eliza Cinteza; Mihaela Balgradean
Journal:  Maedica (Bucur)       Date:  2020-03

5.  Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients.

Authors:  Matthijs C Brouwer; Frank Baas; Arie van der Ende; Diederik van de Beek
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 6.  Diverse applications of electronic-nose technologies in agriculture and forestry.

Authors:  Alphus D Wilson
Journal:  Sensors (Basel)       Date:  2013-02-08       Impact factor: 3.576

7.  Applications and advances in electronic-nose technologies.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2009-06-29       Impact factor: 3.576

8.  Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.

Authors:  Magda K Ellis; Katherine S Elliott; Anna Rautanen; Derrick W Crook; Adrian V S Hill; Stephen J Chapman
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

9.  Mannose-binding lectin and l-ficolin polymorphisms in patients with community-acquired pneumonia caused by intracellular pathogens.

Authors:  Gijs van Kempen; Sabine Meijvis; Henrik Endeman; Bart Vlaminckx; Bob Meek; Ben de Jong; Ger Rijkers; Willem Jan Bos
Journal:  Immunology       Date:  2017-01-24       Impact factor: 7.397

10.  Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia.

Authors:  William W Siljan; Jan C Holter; Ståle H Nymo; Einar Husebye; Thor Ueland; Lillemor Skattum; Vidar Bosnes; Peter Garred; Stig S Frøland; Tom E Mollnes; Pål Aukrust; Lars Heggelund
Journal:  Open Forum Infect Dis       Date:  2018-01-05       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.